Saltos, A., Zheng, H., Arrowood, C., Beasley, G., Ronald, J., El-Haddad, G., … Ready, N. (2022). 1132 Impact of intralesional oncolytic viral therapy targetingin situactivation of CD40 and type 1 interferon signaling pathways on the TME and systemic T cell immunity in murine models and cancer patients. In Regular and Young Investigator Award Abstracts. BMJ Publishing Group Ltd. https://doi.org/10.1136/jitc-2022-sitc2022.1132

Saltos, Andreas, Hong Zheng, Christy Arrowood, Georgia Beasley, James Ronald, Ghassan El-Haddad, Uzma Khan, et al. “1132 Impact of intralesional oncolytic viral therapy targetingin situactivation of CD40 and type 1 interferon signaling pathways on the TME and systemic T cell immunity in murine models and cancer patients.” In Regular and Young Investigator Award Abstracts. BMJ Publishing Group Ltd, 2022. https://doi.org/10.1136/jitc-2022-sitc2022.1132.

Saltos A, Zheng H, Arrowood C, Beasley G, Ronald J, El-Haddad G, et al. 1132 Impact of intralesional oncolytic viral therapy targetingin situactivation of CD40 and type 1 interferon signaling pathways on the TME and systemic T cell immunity in murine models and cancer patients. In: Regular and Young Investigator Award Abstracts. BMJ Publishing Group Ltd; 2022.

Saltos, Andreas, et al. “1132 Impact of intralesional oncolytic viral therapy targetingin situactivation of CD40 and type 1 interferon signaling pathways on the TME and systemic T cell immunity in murine models and cancer patients.” Regular and Young Investigator Award Abstracts, BMJ Publishing Group Ltd, 2022. Crossref, doi:10.1136/jitc-2022-sitc2022.1132.

Saltos A, Zheng H, Arrowood C, Beasley G, Ronald J, El-Haddad G, Khan U, Guerra-Guevara L, Wolf S, Gu L, Wang X, Cantwell M, Antonia S, Beg A, Ready N. 1132 Impact of intralesional oncolytic viral therapy targetingin situactivation of CD40 and type 1 interferon signaling pathways on the TME and systemic T cell immunity in murine models and cancer patients. Regular and Young Investigator Award Abstracts. BMJ Publishing Group Ltd; 2022.